189 related articles for article (PubMed ID: 26462841)
1. The clinical significance of vascular endothelial growth factor in malignant ascites.
Zhan N; Dong WG; Wang J
Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
[TBL] [Abstract][Full Text] [Related]
2. Role of VEGF and CD44v6 in differentiating benign from malignant ascites.
Dong WG; Sun XM; Yu BP; Luo HS; Yu JP
World J Gastroenterol; 2003 Nov; 9(11):2596-600. PubMed ID: 14606105
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of vascular endothelial growth factor and endostatin levels in the differential diagnosis of malignant and benign ascites.
Cheng D; Liang B; Kong H
Med Oncol; 2012 Jun; 29(2):1397-402. PubMed ID: 21556933
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
[TBL] [Abstract][Full Text] [Related]
5. A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.
Abdel-Razik A; Mousa N; Elalfy H; Sheta TF; Awad M; Abdelsalam M; Elhelaly R; Elzehery R; Gouda NS; Eldars W
J Gastrointest Cancer; 2017 Mar; 48(1):50-57. PubMed ID: 27614744
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites.
Nascimento I; Schaer R; Lemaire D; Freire S; Paule B; Carvalho S; Meyer R; Schaer-Barbosa H
APMIS; 2004 Sep; 112(9):585-7. PubMed ID: 15601306
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.
Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R
J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer.
Maae E; Olsen DA; Steffensen KD; Jakobsen EH; Brandslund I; Sørensen FB; Jakobsen A
Breast Cancer Res Treat; 2012 May; 133(1):257-65. PubMed ID: 22270936
[TBL] [Abstract][Full Text] [Related]
10. Elevated VEGF concentrations in ascites and serum predict adverse prognosis in ovarian cancer.
Liang B; Guo Z; Li Y; Liu C
Scand J Clin Lab Invest; 2013; 73(4):309-14. PubMed ID: 23473018
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up.
Rudlowski C; Pickart AK; Fuhljahn C; Friepoertner T; Schlehe B; Biesterfeld S; Schroeder W
Int J Gynecol Cancer; 2006; 16 Suppl 1():183-9. PubMed ID: 16515588
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients.
Lee HK; Chae HS; Kim JS; Kim HK; Cho YS; Rho SY; Kang JH; Cho SG; Jang HS; Han K
Yonsei Med J; 2008 Jun; 49(3):429-35. PubMed ID: 18581593
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites.
Sun J; Chang YX; Niu CY
Tumour Biol; 2017 Nov; 39(11):1010428317726840. PubMed ID: 29130388
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of vascular endothelial growth factor mRNA level is significantly related to progression and prognosis of oral squamous cell carcinomas.
Ko HH; Lee JJ; Chen HM; Kok SH; Yen-Ping Kuo M; Cheng SJ; Chiang CP
J Formos Med Assoc; 2015 Jul; 114(7):605-11. PubMed ID: 26058869
[TBL] [Abstract][Full Text] [Related]
17. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Wang Q; Diao X; Sun J; Chen Z
Urol Oncol; 2013 Apr; 31(3):312-7. PubMed ID: 21367627
[TBL] [Abstract][Full Text] [Related]
19. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients.
Dalal V; Kumar R; Kumar S; Sharma A; Kumar L; Sharma JB; Roy KK; Singh N; Vanamail P
Clin Chim Acta; 2018 Jul; 482():27-32. PubMed ID: 29572186
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma.
Demirag F; Unsal E; Yilmaz A; Caglar A
Chest; 2005 Nov; 128(5):3382-7. PubMed ID: 16304288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
